TABLE 2.
Reported Preference of Biosimilar Naming Convention by Employment Type
| Employment Type | Nonproprietary Only % (n) | Nonproprietary Plus Suffix % (n) | Nonproprietary Plus Prefix % (n) | Unique Brand Name % (n) |
|---|---|---|---|---|
| Hospital (n = 116) | 17.9 (21) | 44.4 (52) | 29.1 (34) | 7.7 (9) |
| Outpatient pharmaciesa (n = 124) | 29.8 (37) | 45.2 (56) | 13.7 (17) | 11.3 (14) |
| Specialty pharmacy (n = 26) | 38.5 (10) | 34.6 (9) | 19.2 (5) | 7.7 (2) |
| MCOs (n = 233) | 31.3 (73) | 50.2 (117) | 6.9 (16) | 11.6 (27) |
| Manufacturer (n = 78) | 16.7 (13) | 50.0 (39) | 15.3 (12) | 17.9 (14) |
| Academia (n = 37) | 21.6 (8) | 43.2 (16) | 29.7 (11) | 5.4 (2) |
| Other/unreported (n = 139) | 25.9 (36) | 52.5 (73) | 8.6 (12) | 12.9 (18) |
| Total | 26.3 (198) | 48.1 (362) | 14.2 (107) | 11.4 (86) |
a Includes those reporting independent, small chain, large chain, clinic nondispensing, and clinic dispensing.
MCO = managed care organization.